Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency. | Blood | 2025 | 40857665 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| Comprehensive Receptor Repertoire and Functional Analysis of Peripheral NK Cells in Soft Tissue Sarcoma Patients. | Cancers (Basel) | 2025 | 40805205 | PubTator, text mining | PubMed |
| Multimodal profiling reveals tissue-directed signatures of human immune cells altered with age. | Nat Immunol | 2025 | 40804529 | PubTator, text mining | PubMed |
| Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies. | Regen Ther | 2025 | 40704043 | PubTator, text mining | PubMed |
| Effects of a Low Versus Moderate-High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo-HSCT-The ANIMAL Exploratory Randomized Controlled Trial. | Pediatr Blood Cancer | 2025 | 40457554 | PubTator, text mining | PubMed |
| Inhibition of MCP1 (CCL2) Enhances Antitumor Activity of NK Cells Against HCC Cells Under Hypoxia. | Int J Mol Sci | 2025 | 40430040 | PubTator, text mining | PubMed |
| Spatial mapping of innate lymphoid cells in human lymphoid tissues and lymphoma at single-cell resolution. | Nat Commun | 2025 | 40374674 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Pathways in Preinfusion Chimeric Antigen Receptor (CAR) T-cell Products Associated With Cytokine Release Syndrome. | Cureus | 2025 | 40370902 | PubTator, text mining | PubMed |
| Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy. | Front Immunol | 2025 | 40370457 | PubTator, text mining | PubMed |
| The Influence of the COVID-19 Pandemic in NK Cell Subpopulations from CML Patients Enrolled in the Argentina Stop Trial. | Cells | 2025 | 40358152 | PubTator, text mining | PubMed |
| IL-17A-producing NKp44(-) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue. | Nat Commun | 2025 | 40280932 | PubTator, text mining | PubMed |
| Cytokine Expression and Cytolytic Effect of Natural Killer Cells are Suppressed in Septic Shock. | Scand J Immunol | 2025 | 40254928 | PubTator, text mining | PubMed |
| The impact of a single HIIT intervention on the mobilization of NK cells and ILCs in adolescents and young adults (AYA) undergoing cancer treatment: an interventional controlled trial. | BMC Cancer | 2025 | 40229731 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing. | J Immunother Cancer | 2025 | 40164474 | PubTator, text mining | PubMed |
| Decreased surface receptors, function, and suboptimal osteoclasts-induced cell expansion in natural killer (NK) cells of elderly subjects. | Aging (Albany NY) | 2025 | 40146570 | PubTator, text mining | PubMed |
| Modification of soluble dietary fiber from quinoa bran and investigation of its anticancer activity in vitro. | J Sci Food Agric | 2025 | 40125799 | PubTator, text mining | PubMed |
| Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease. | Hepatol Int | 2025 | 40085416 | PubTator, text mining | PubMed |
| Characterization of the complete mitochondrial genomes of Corynosoma bullosum (von Linstow, 1892) and C. evae Zdzitowiecki, 1984 (Acanthocephala: Polymorphida), and the phylogenetic implications. | J Helminthol | 2025 | 39924663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=4